Bank of America Corporation »

Black Diamond Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $160k 57k 2.81
2023-09-30 $1.7k 596 2.87
2023-06-30 $60 12 5.00
2023-03-31 $24k 13k 1.89
2022-12-31 $23k 13k 1.80
2022-06-30 $123k 50k 2.46
2021-12-31 $316k 59k 5.34
2021-06-30 $571k 47k 12.18
2021-03-31 $1.3M 53k 24.26
2020-12-31 $1.9M 58k 32.07
2020-09-30 $881k 29k 30.31
2020-06-30 $501k 12k 42.16
2020-03-31 $285k 11k 25.05